In Situ Transformable Nanoparticle Effectively Suppresses Bladder Cancer by Damaging Mitochondria and Blocking Mitochondrial Autophagy Flux
Advanced Science · 2025
DOI: 10.1002/advs.202409425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yulin Lv und 13 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory, of Molecular Probes and Targeted Theranostics, Harbin Medical University, Harbin, 150001, China. Hauptthemen laut MEDLINE: Autophagy, Mitochondria, Nanoparticles, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Research Program of China, Regional Key Project of National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor therapeutic strategies based on mitochondrial damage have become an emerging trend. However, the low drug delivery efficiency caused by lysosomal sequestration and the activation of protective mitochondrial autophagy severely restricts the therapeutic efficacy. Herein, an in situ transformable nanoparticle named KCKT is developed to promote lysosomal escape and directly damage mitochondria while blocking mitochondrial autophagy. KCKT exhibits acid responsiveness for precise self‐assembly into nanofibers within the lysosomes of cancer cells. The massive accumulation of nanofibers and excessive production of reactive oxygen species (ROS) under sonodynamic therapy synergistically induce lysosomal damage. This facilitates the escape of nanofibers from lysosomal sequestration, thereby enhancing drug delivery. Subsequently, the escaped nanofibers specifically aggregate around the mitochondria for long‐term retention and generate ROS under ultrasound irradiation to induce mitochondrial damage. Notably, due to lysosomal dysfunction, damaged mitochondria cannot be cleared by autophagy, further aggravating oxidative damage. These results reveal that KCKT effectively improves drug delivery and mitochondria‐targeted therapy efficiency by blocking protective autophagy. These findings hold significant potential for advancing the field of mitochondria‐targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory, of Molecular Probes and Targeted Theranostics, Harbin Medical University, Harbin, 150001, China.
- Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
- CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST) No. 11 Beiyitiao, Zhongguancun, Beijing, 100190…
- Department of Neurosurger, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
- Key Laboratory of the Fourth Hospital of Harbin Medical University, Harbin, 150001, China.
- Department of Urology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
ORCID-Profile: Wanhai Xu
Förderung
- National Key R&D Program of China
- National Natural Science Research Program of China
- Regional Key Project of National Natural Science Foundation of China
- Key Research and Development Program of Heilongjiang Province
- National Key Research and Development Program of China
Zitieren
APA
Lv, Y., Song, B., Yang, G., Wang, Y., Wu, Z., Si, M., Yang, Z., Chen, H., Liu, C., Li, M., Zhang, Y., Qiao, Z., Wang, L., & Xu, W. (2025). In Situ Transformable Nanoparticle Effectively Suppresses Bladder Cancer by Damaging Mitochondria and Blocking Mitochondrial Autophagy Flux. Advanced Science. https://doi.org/10.1002/advs.202409425
Vancouver
Lv Y, Song B, Yang G, Wang Y, Wu Z, Si M, et al. In Situ Transformable Nanoparticle Effectively Suppresses Bladder Cancer by Damaging Mitochondria and Blocking Mitochondrial Autophagy Flux. Advanced Science. 2025. doi:10.1002/advs.202409425
BibTeX
@article{Lv2025,
author = {Lv, Yulin and Song, Benli and Yang, Guang and Wang, Yuting and Wu, Zeyu and Si, Minggui and Yang, Zongzheng and Chen, Huilin and Liu, Chen and Li, Min and Zhang, Yinshi and Qiao, Zengying and Wang, Lu and Xu, Wanhai},
title = {In Situ Transformable Nanoparticle Effectively Suppresses Bladder Cancer by Damaging Mitochondria and Blocking Mitochondrial Autophagy Flux},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202409425}
}
EUVIMED